Targeted Info Could Help Reduce Racial Disparities In Knee Implants, CDC Says
This article was originally published in The Gray Sheet
Executive Summary
Despite multiple efforts over the past decade, racial disparities continued to grow between white and black Medicare patients receiving total knee replacements between 2000 and 2006, according to a Feb. 20 report from the Centers for Disease Control and Prevention
You may also be interested in...
Who’s Hired? Hikma Recruits New US Generics President
A flurry of top level recruitments made headlines in the past weeks, with the likes of Hikma, Lupin, and Viatris announcing new hires while focusing on their targets for the year.
Organon And Henlius Complete Phase III For Denosumab
Having earlier this year reported positive Phase I data for their partnered denosumab biosimilar candidate, Organon and Shanghai Henlius Biotech have now announced that their HLX14 version has met primary endpoints in a Phase III study.
Taro Agrees $36m Securities Settlement Over US Price-Fixing Claims
Sun’s Taro subsidiary is looking to move forward with an eight-figure settlement deal in the US, after plaintiffs including a firefighters’ pension fund accused the firm of misleading investors via its involvement in generic price fixing, leading to a fall in the price of its securities.